Druk Holding and Investments

Druk Holding and Investments (DHI) is the commercial arm of the Royal Government of Bhutan, established in 2007 to manage and grow the nation's wealth through strategic investments. While it operates as a diversified conglomerate, DHI has a significant and growing footprint in the life sciences and healthcare sectors. Through its subsidiary, Menjong Sorig Pharmaceutical, the company commercializes traditional Bhutanese Sowa Rigpa medicines and high-quality herbal products. DHI is also spearheading innovation through its Research & Development division, which focuses on biotechnology, genomics, and digital health solutions. The organization is a key driver behind the Gelephu Mindfulness City initiative, which aims to establish a global hub for wellness and biotech research. By bridging traditional knowledge with modern science, DHI seeks to improve healthcare outcomes both within Bhutan and for the international market.